vs
Side-by-side financial comparison of Stoke Therapeutics, Inc. (STOK) and T1 Energy Inc. (TE). Click either name above to swap in a different company.
T1 Energy Inc. is the larger business by last-quarter revenue ($210.5M vs $158.6M, roughly 1.3× Stoke Therapeutics, Inc.). Stoke Therapeutics, Inc. runs the higher net margin — 71.2% vs -62.0%, a 133.2% gap on every dollar of revenue. Stoke Therapeutics, Inc. produced more free cash flow last quarter ($131.7M vs $55.0M).
Stoke Therapeutics, Inc. is a clinical-stage biotechnology company developing innovative RNA-targeted therapies for severe rare genetic diseases. Its lead candidates address unmet needs for Dravet syndrome, a rare epilepsy, and other neurological monogenic disorders, serving patients across North America and global markets.
Sony Energy Devices Corporation , is a Japanese multinational company specializing in a variety of areas in the energy industry, and is a wholly owned subsidiary and part of the Devices Group of Sony. The company was established in February 1975 in Fukushima, Japan.
STOK vs TE — Head-to-Head
Income Statement — Q1 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $158.6M | $210.5M |
| Net Profit | $112.9M | $-130.6M |
| Gross Margin | — | 10.0% |
| Operating Margin | 70.2% | -45.0% |
| Net Margin | 71.2% | -62.0% |
| Revenue YoY | 3661.1% | — |
| Net Profit YoY | 528.0% | -375.2% |
| EPS (diluted) | $1.90 | $-0.87 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | — | $210.5M | ||
| Q2 25 | — | $132.8M | ||
| Q1 25 | $158.6M | $53.5M | ||
| Q4 24 | $22.6M | — | ||
| Q3 24 | — | $0 | ||
| Q2 24 | — | $0 | ||
| Q1 24 | — | $0 | ||
| Q2 23 | $-2.5M | — |
| Q3 25 | — | $-130.6M | ||
| Q2 25 | — | $-31.9M | ||
| Q1 25 | $112.9M | $-16.2M | ||
| Q4 24 | $-10.5M | — | ||
| Q3 24 | — | $-27.5M | ||
| Q2 24 | — | $-27.0M | ||
| Q1 24 | — | $-28.5M | ||
| Q2 23 | $-30.7M | — |
| Q3 25 | — | 10.0% | ||
| Q2 25 | — | 24.7% | ||
| Q1 25 | — | 33.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q2 23 | — | — |
| Q3 25 | — | -45.0% | ||
| Q2 25 | — | -22.0% | ||
| Q1 25 | 70.2% | -44.2% | ||
| Q4 24 | -60.4% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q2 23 | 1340.7% | — |
| Q3 25 | — | -62.0% | ||
| Q2 25 | — | -24.0% | ||
| Q1 25 | 71.2% | -30.4% | ||
| Q4 24 | -46.4% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q2 23 | 1235.6% | — |
| Q3 25 | — | $-0.87 | ||
| Q2 25 | — | $-0.21 | ||
| Q1 25 | $1.90 | $-0.11 | ||
| Q4 24 | $-0.15 | — | ||
| Q3 24 | — | $-0.20 | ||
| Q2 24 | — | $-0.19 | ||
| Q1 24 | — | $-0.20 | ||
| Q2 23 | $-0.69 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $274.8M | $34.1M |
| Total DebtLower is stronger | — | $547.3M |
| Stockholders' EquityBook value | $350.1M | $96.9M |
| Total Assets | $406.9M | $1.4B |
| Debt / EquityLower = less leverage | — | 5.65× |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $34.1M | ||
| Q2 25 | — | $8.5M | ||
| Q1 25 | $274.8M | $48.9M | ||
| Q4 24 | $128.0M | — | ||
| Q3 24 | — | $181.9M | ||
| Q2 24 | — | $219.6M | ||
| Q1 24 | — | $249.9M | ||
| Q2 23 | $192.1M | — |
| Q3 25 | — | $547.3M | ||
| Q2 25 | — | $591.2M | ||
| Q1 25 | — | $603.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $602.3M | ||
| Q2 23 | — | — |
| Q3 25 | — | $96.9M | ||
| Q2 25 | — | $183.9M | ||
| Q1 25 | $350.1M | $201.9M | ||
| Q4 24 | $229.0M | — | ||
| Q3 24 | — | $538.7M | ||
| Q2 24 | — | $561.6M | ||
| Q1 24 | — | $582.3M | ||
| Q2 23 | $190.2M | — |
| Q3 25 | — | $1.4B | ||
| Q2 25 | — | $1.4B | ||
| Q1 25 | $406.9M | $1.4B | ||
| Q4 24 | $271.6M | — | ||
| Q3 24 | — | $615.0M | ||
| Q2 24 | — | $644.4M | ||
| Q1 24 | — | $670.3M | ||
| Q2 23 | $256.9M | — |
| Q3 25 | — | 5.65× | ||
| Q2 25 | — | 3.21× | ||
| Q1 25 | — | 2.99× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 1.03× | ||
| Q2 23 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $131.8M | $63.9M |
| Free Cash FlowOCF − Capex | $131.7M | $55.0M |
| FCF MarginFCF / Revenue | 83.0% | 26.1% |
| Capex IntensityCapex / Revenue | 0.1% | 4.2% |
| Cash ConversionOCF / Net Profit | 1.17× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-42.3M |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $63.9M | ||
| Q2 25 | — | $33.4M | ||
| Q1 25 | $131.8M | $-44.8M | ||
| Q4 24 | $-23.2M | — | ||
| Q3 24 | — | $-28.4M | ||
| Q2 24 | — | $-28.0M | ||
| Q1 24 | — | $-16.2M | ||
| Q2 23 | $-21.8M | — |
| Q3 25 | — | $55.0M | ||
| Q2 25 | — | $10.6M | ||
| Q1 25 | $131.7M | $-74.0M | ||
| Q4 24 | $-23.2M | — | ||
| Q3 24 | — | $-34.0M | ||
| Q2 24 | — | $-35.6M | ||
| Q1 24 | — | $-37.7M | ||
| Q2 23 | $-22.6M | — |
| Q3 25 | — | 26.1% | ||
| Q2 25 | — | 8.0% | ||
| Q1 25 | 83.0% | -138.4% | ||
| Q4 24 | -102.7% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q2 23 | 912.5% | — |
| Q3 25 | — | 4.2% | ||
| Q2 25 | — | 17.2% | ||
| Q1 25 | 0.1% | 54.5% | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q2 23 | -33.8% | — |
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 1.17× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q2 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
STOK
Segment breakdown not available.
TE
| Related Party | $120.1M | 57% |
| Nonrelated Party | $90.4M | 43% |
